BRIEF-Ophthotech announces results from phase 3 trial of Fovista
August 14, 2017 at 06:40 AM EDT
* Ophthotech announces results from third phase 3 trial of Fovista® in wet age-related macular degeneration
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.